EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+37.13%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$199M
AUM Growth
+$199M
(-2.4%)
Cap. Flow
-$12.3M
Cap. Flow
% of AUM
-6.18%
Top 10 Holdings %
Top 10 Hldgs %
61.97%
Holding
84
New
13
Increased
17
Reduced
19
Closed
23
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$13.3M |
| 2 |
Merck
MRK
|
$10.6M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$8.72M |
| 4 |
Danaher
DHR
|
$3.87M |
| 5 |
Sanofi
SNY
|
$3.03M |
Top Sells
| 1 |
QCP
Quality Care Properties, Inc.
QCP
|
$23.1M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$7.94M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$6.54M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$6.25M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$3.78M |
Sector Composition
| 1 | Healthcare | 79.94% |
| 2 | Industrials | 8.6% |
| 3 | Communication Services | 0.58% |
| 4 | Real Estate | 0.46% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
1
DELISTED
Zogenix, Inc.
ZGNX
| $20.8M | 9.13% | 419,279 +268,434 | +178% | +$13.3M |
|
|
RCM
2
DELISTED
R1 RCM Inc. Common Stock
RCM
| $17.1M | 7.51% | 1,685,087 -122,989 | -7% | -$1.25M |
|
|
AMRN
3
Amarin Corp
AMRN
$311M
| $16.2M | 7.11% | 995,700 +535,700 | +116% | +$8.72M |
|
|
4
Sanofi
SNY
$121B
| $12.5M | 5.51% | 280,872 +67,900 | +32% | +$3.03M |
|
5
GSK
GSK
$79.9B
| $11.7M | 5.15% | 289,284 +36,700 | +15% | +$1.49M |
|
|
6
Merck
MRK
$210B
| $10.6M | 4.63% | +147,800 | New | +$10.6M |
|
|
RDUS
7
DELISTED
Radius Health, Inc.
RDUS
| $9.42M | 4.13% | 528,992 +60,411 | +13% | +$1.08M |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $9.27M | 4.07% | 48,092 +13,270 | +38% | +$2.56M |
|
|
TLGT
9
DELISTED
Teligent, Inc
TLGT
| $8.34M | 3.66% | 2,112,098 | – | – |
|
|
AERI
10
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $7.43M | 3.26% | 120,711 -106,191 | -47% | -$6.54M |
|
11
Sarepta Therapeutics
SRPT
$1.78B
| $6.81M | 2.99% | 42,194 +2,194 | +5% | +$354K |
|
|
SAGE
12
DELISTED
Sage Therapeutics
SAGE
| $6.16M | 2.7% | 43,621 +220 | +0.5% | +$31.1K |
|
13
Abbott
ABT
$231B
| $5.51M | 2.42% | 75,100 +29,200 | +64% | +$2.14M |
|
|
ARNA
14
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.49M | 2.41% | 119,371 -14,780 | -11% | -$680K |
|
15
The Ensign Group
ENSG
$9.91B
| $5.11M | 2.24% | 134,655 -31,425 | -19% | -$1.19M |
|
|
16
Danaher
DHR
$147B
| $3.87M | 1.7% | +35,604 | New | +$3.87M |
|
17
Xenon Pharmaceuticals
XENE
$2.98B
| $2.77M | 1.22% | +209,739 | New | +$2.77M |
|
18
Medtronic
MDT
$119B
| $2.65M | 1.16% | +26,800 | New | +$2.65M |
|
19
AnaptysBio
ANAB
$569M
| $2.25M | 0.99% | 22,524 -10,110 | -31% | -$1.01M |
|
20
Madrigal Pharmaceuticals
MDGL
$9.76B
| $2.01M | 0.88% | 9,400 +4,900 | +109% | +$1.05M |
|
|
WMGI
21
DELISTED
Wright Medical Group Inc
WMGI
| $1.93M | 0.85% | +66,600 | New | +$1.93M |
|
|
AFMD
22
DELISTED
Affimed
AFMD
| $1.88M | 0.83% | 432,727 +45,865 | +12% | +$200K |
|
23
argenx
ARGX
$43.6B
| $1.79M | 0.78% | 23,554 -830 | -3% | -$62.9K |
|
24
Apellis Pharmaceuticals
APLS
$3.48B
| $1.78M | 0.78% | 100,295 +1,900 | +2% | +$33.8K |
|
|
ARQL
25
DELISTED
Arqule Inc
ARQL
| $1.64M | 0.72% | 289,618 -84,702 | -23% | -$479K |
|